Biogen Inc (NASDAQ:BIIB) over-valued by 14%
| Website | https://www.biogen.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $40,851,947,520 |
| Beta | 0.56693 |
| Average Volume | $1,281,540 |
| Last Dividend | 0% |
| Price on Feb 3, 2021 | $268.17 |
| Autochartist™ Valuation | $231.07 |
| Conclusion |
14% over-valued |
| Download Report |
